Skip to main content
GRDN logo

Guardian Pharmacy Services, Inc.

GRDNNYSEHealthcareMedical Care Facilities

$39.47Today:- (-)1Y +59.04%

As of Oct 16, 2026 close

Market cap
$2.53B
P/E (TTM)
38.43
Forward P/E
-
Dividend yield
-
52-week range
$23.37$48.33
Volume (live)
-
Avg. volume (3M)
622.56K

Guardian Pharmacy Services (GRDN) Stock Price & Financial Analysis

Guardian Pharmacy Services Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$39.07 - $39.86
52-Week High$48.33
52-Week Low$23.37
Open$39.68
Volume (last close)451.03K
Average Volume (3M)622.56K
Earnings & Profitability
Revenue (TTM)1.46B
Net Income (TTM)65.91M
Free Cash Flow (TTM)79.78M
EPS (TTM)$1.04
Profit Margin4.50%
Operating Margin5.84%
Return on Equity (ROE)25.58%
Debt to Equity0.14
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Size & Valuation
Market Cap2.53B
Shares Outstanding63.84M
P/E Ratio (TTM)38.43
Price to Sales (P/S)1.73
Price to Book (P/B)9.83
EV/EBITDA20.67
Technical Indicators
50-Day MA$40.90
200-Day MA$37.53
1-Year Change+59.04%

Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology

Compare GRDN with other stocks

Guardian Pharmacy Services at a Glance

As of the Oct 16, 2026 close, Guardian Pharmacy Services (GRDN) has a market capitalization of $2.53B. The stock trades at 38.4× trailing earnings and 1.7× sales. Over the trailing twelve months it earned $65.91M on revenue of $1.46B (a 4.5% profit margin) and generated $79.78M of free cash flow. Revenue grew 10.3% year over year.

As of its latest reported balance sheet, it holds $89.81M in cash and securities against $35.24M of debt, a net cash position of $54.57M.

Guardian Pharmacy Services does not currently pay a dividend.

The share price is up 59.0% over the past year. At $39.47 (the Oct 16, 2026 close) it sits within its 52-week range of $23.37 to $48.33, above its 200-day moving average of $37.53.

Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $49.80, 26.2% above the Oct 16, 2026 close.

Frequently Asked Questions About Guardian Pharmacy Services

What is the current stock price for GRDN?

As of the Oct 16, 2026 close, GRDN stock trades at $39.47. The 52-week range is $23.37–$48.33, with a day range of $39.07–$39.86.

What is the P/E ratio for GRDN?

As of the Oct 16, 2026 close, Guardian Pharmacy Services's trailing twelve-month (TTM) P/E ratio is 38.4, meaning investors pay $38.4 for every $1 of annual earnings. Guardian Pharmacy Services operates in the Healthcare sector.

Does GRDN pay dividends?

Guardian Pharmacy Services does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.

What do analysts recommend for GRDN?

Based on ratings from 6 professional analysts over the last 90 days, the consensus for GRDN is Buy. The average 12-month price target is $49.80, a 26.2% upside from the Oct 16, 2026 close of $39.47.

What is the market cap of GRDN?

As of the Oct 16, 2026 close, Guardian Pharmacy Services's market capitalization is $2.52B, classifying it as a mid-cap company. Guardian Pharmacy Services operates in the Healthcare sector within the Medical Care Facilities industry.